JBIO — JADE BIOSCIENCES INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 162 家机构在其最新 13F 申报中持有 JBIO(JADE BIOSCIENCES INC),合计申报市值 $1.60B,对应 72.25M 股。按股数计算较上季度增持 20.2%(+8.80M 股),申报市值环比上升 90.0%。持仓集中度较高:前五大持有人占申报市值的 37.2%,前十大的集中度为 56.2%。
与上一季度相比,55 家新建仓位、65 家加仓、25 家减仓、18 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
JADE BIOSCIENCES INC(JBIO)的主要机构持有人包括 Jupiter Topco LLC、Fidelity Management & Research (FMR)、Fairmount Funds Management LLC,按 13F 申报市值在本页 210 家持有人中排名居前。
JBIO 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 101 | 35.70M | $505.56M | +20.8% |
| Q2 2026 | 162 | 72.25M | $1.60B | +20.2% |
| Q1 2026 | 125 | 50.00M | $702.10M | -4.3% |
| Q4 2025 | 110 | 47.45M | $731.67M | +35.1% |
| Q3 2025 | 81 | 31.86M | $274.81M | -0.5% |
| Q2 2025 | 74 | 31.69M | $316.75M | — |
表内 6 个季度中,机构持股合计增加 13%(Q2 2025 → Q3 2026);单季变动最大的是 Q4 2025(+35.1%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 9.81M | $137.83M | 0.01% | 增持 | |
| 3.81M | $57.26M | 0.01% | 增持 | |
| 3.37M | $47.30M | 0.00% | 增持 | |
| 2.60M | $36.57M | 0.00% | 增持 | |
| 2.35M | $32.96M | 0.00% | 增持 | |
| 1.81M | $25.40M | 9.28% | 增持 | |
| 1.47M | $20.83M | 0.00% | 持有 | |
| 1.21M | $16.94M | 0.02% | 增持 | |
| 1.20M | $16.89M | 0.00% | 增持 | |
| 991.78K | $13.93M | 12.77% | 持有 | |
| 760.35K | $10.68M | 0.50% | 减持 | |
| 666.92K | $9.37M | 0.03% | 增持 | |
| 550.89K | $7.74M | 0.01% | 减持 | |
| 528.37K | $7.42M | 0.01% | 增持 | |
| 521.68K | $7.33M | 0.00% | 增持 | |
| 458.89K | $6.45M | 0.01% | 减持 | |
| 364.63K | $5.12M | 0.00% | 增持 | |
| 342.29K | $4.81M | 0.01% | 增持 | |
| 302.81K | $4.25M | 0.04% | 增持 | |
| 221.37K | $3.11M | 0.00% | 增持 | |
| 180.46K | $2.54M | 0.01% | 减持 | |
| 179.43K | $2.52M | 0.00% | 增持 | |
| 174.37K | $2.47M | 0.00% | 新进 | |
| 171.97K | $2.42M | 0.00% | 增持 | |
| 139.53K | $1.96M | 0.00% | 新进 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
Q4 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 6.89M | $106.38M | 0.01% | 增持 | |
| 4.55M | $70.26M | 5.35% | 增持 | |
| 3.67M | $56.64M | 0.58% | 增持 | |
| 3.34M | $51.55M | 0.98% | 新进 | |
| 3.22M | $49.69M | 2.45% | 持有 | |
| 2.87M | $44.29M | 0.00% | 增持 | |
| 2.10M | $32.34M | 0.00% | 增持 | |
| 1.64M | $25.32M | 0.15% | 新进 | |
| 1.58M | $24.34M | 14.30% | 新进 | |
| 1.53M | $23.54M | 15.59% | 持有 | |
| 1.45M | $22.36M | 0.22% | 持有 | |
| 1.40M | $21.61M | 6.23% | 增持 | |
| 968.80K | $14.95M | 1.54% | 增持 | |
| 887.18K | $13.69M | 0.09% | 减持 | |
| 875.27K | $13.51M | 0.02% | 增持 | |
| 867.28K | $13.38M | 0.02% | 新进 | |
| 841.81K | $12.99M | 0.00% | 增持 | |
| 806.27K | $12.44M | 4.03% | 增持 | |
| 796.74K | $12.29M | 0.45% | 持有 | |
| 714.96K | $11.03M | 0.67% | 增持 | |
| 642.92K | $9.92M | 0.00% | 增持 | |
| 558.47K | $8.62M | 0.03% | 新进 | |
| 531.16K | $8.20M | 0.17% | 持有 | |
| 427.61K | $6.60M | 0.87% | 新进 | |
| 395.00K | $6.09M | 0.44% | 减持 |
Q3 2025 — 25 家基金
Q2 2025 — 25 家基金
新建仓(Q2 2026)
- Jupiter Topco LLC 6.27M 股 · $139.37M
- Paradigm Biocapital Advisors LP 2.86M 股 · $63.49M
- Franklin Resources 2.79M 股 · $62.04M
- ADAGE CAPITAL PARTNERS GP, L.L.C. 1.91M 股 · $42.46M
- Polar Capital Holdings Plc 1.85M 股 · $41.04M
- GEODE CAPITAL MANAGEMENT, LLC 985.18K 股 · $21.90M
- Pictet Asset Management Holding SA 733.77K 股 · $16.30M
- Blackstone Inc. 435.32K 股 · $9.67M
- Walleye Capital LLC 365.27K 股 · $8.12M
- LORD, ABBETT & CO. LLC 226.61K 股 · $5.04M
- AMERIPRISE FINANCIAL INC 107.05K 股 · $2.38M
- Woodline Partners LP 100.27K 股 · $2.23M
完全清仓(较上季)
- Janus Henderson Group 卖出 3.11M 股 · $43.56M
- GREAT POINT PARTNERS LLC 卖出 964.46K 股 · $13.55M
- STATE STREET CORP 卖出 655.69K 股 · $9.21M
- DRIEHAUS CAPITAL MANAGEMENT LLC 卖出 635.50K 股 · $8.93M
- RTW INVESTMENTS, LP 卖出 573.21K 股 · $8.05M
- ORBIMED ADVISORS LLC 卖出 185.01K 股 · $2.60M
- STEMPOINT CAPITAL LP 卖出 154.03K 股 · $2.16M
- Y-Intercept (Hong Kong) Ltd 卖出 25.13K 股 · $353.09K
- Qube Research & Technologies Ltd 卖出 24.79K 股 · $348.33K
- HRT FINANCIAL LP 卖出 24.42K 股 · $343.00K
- ADAR1 Capital Management, LLC 卖出 20.00K 股 · $281.00K
- GSA CAPITAL PARTNERS LLP 卖出 19.55K 股 · $275.00K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) | 9.81M | 9.13M | 7.09M | 6.89M | 4.89M | 4.84M |
| Franklin Resources | 3.81M | 2.79M | — | — | — | — |
| BlackRock Inc | 3.37M | 2.80M | 2.31M | 2.87M | 2.15M | 1.71M |
| STATE STREET CORP | 2.60M | — | 655.69K | 642.92K | 499.29K | 318.77K |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.35M | 2.24M | 1.80M | — | — | — |
| Remedium Capital Partners, LLC | 1.81M | 1.58M | 1.58M | 1.58M | — | — |
| JPMorgan Chase & Co | 1.47M | 1.48M | 15.86K | 20.60K | 13.20K | 15.37K |
| Pictet Asset Management Holding SA | 1.21M | 733.77K | — | — | — | — |
| Geode Capital Management | 1.20M | 985.18K | 822.52K | 841.81K | 665.91K | 676.43K |
| Versant Venture Management, LLC | 991.78K | 991.78K | 1.53M | 1.53M | 1.53M | 1.53M |
| Affinity Asset Advisors, LLC | 760.35K | 840.35K | 639.96K | 714.96K | 65.32K | 65.32K |
| LORD, ABBETT & CO. LLC | 666.92K | 226.61K | — | — | — | — |
| Aberdeen Group plc | 550.89K | 621.11K | 867.28K | 867.28K | — | — |
| BNP PARIBAS FINANCIAL MARKETS | 528.37K | 199.43K | 28.62K | 9.87K | 14.93K | 3.22K |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 521.68K | 461.53K | 211.32K | — | — | — |
| Marshall Wace | 458.89K | 585.76K | 944.78K | 875.27K | 38.08K | — |
| VANGUARD FIDUCIARY TRUST CO | 364.63K | 304.87K | 219.50K | — | — | — |
| Connor, Clark & Lunn Investment Management Ltd. | 342.29K | 217.16K | 169.05K | 67.23K | — | — |
| Jump Financial, LLC | 302.81K | 172.75K | 11.80K | — | — | — |
| UBS Group AG | 221.37K | 127.58K | 65.02K | 96.79K | 19.83K | 21.04K |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold JBIO?
As of 2026-Q2, 162 institutional funds reported holding JBIO (JADE BIOSCIENCES INC) in SEC 13F filings, with a combined reported value of $1.60B.
How many shares of JBIO do institutions own?
13F filers reported 72.25M shares of JBIO, worth $1.60B in aggregate at the end of 2026-Q2.
Is institutional ownership of JBIO rising or falling?
Share counts moved +20.2% versus the prior quarter — accumulation.
Who are the top institutional holders of JBIO?
The largest 13F holders are Jupiter Topco LLC, Fidelity Management & Research (FMR), Fairmount Funds Management LLC, RA CAPITAL MANAGEMENT, L.P., Venrock Adviser, LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of JADE BIOSCIENCES INC?
The major shareholders of JADE BIOSCIENCES INC (JBIO) by reported 13F value are Jupiter Topco LLC, Fidelity Management & Research (FMR), Fairmount Funds Management LLC, RA CAPITAL MANAGEMENT, L.P., Venrock Adviser, LLC, among 210 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.